TP53 and colorectal carcinoma: In this sense, some autoantibodies have been also postulated as associated to the progression of the disease, with high autoantibody levels against VTI2 and p53 associated to CRC metastasis, or against GRP78 and SPAG9 to early stages of the disease (15, 149, 164).